Catalyst Event

Alteogen Inc (196170) · Other

From Akros SCHK HK-Korea Quality Factor Index (ASHKQLT)

5/14/2026, 12:00:00 AM

OtherSentiment: Positive

A US patent board invalidated a key patent of competitor Halozyme on May 14, 2026, reducing legal risks for Alteogen's partner Merck and leading to a significant stock price increase.

Korean Translation

2026년 5월 14일 미국 특허심판원의 경쟁사 특허 무효 결정으로 파트너사 머크의 법적 리스크가 해소되며 주가가 급등함.

Related Recent Events

View Full Timeline